Skip to content
10-Q

Quarterly Report

EXACT SCIENCES CORP

0001124140-25-000043

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 188.64M sh
Shares Diluted Q1 2025 · Mar 31, 2025 186.81M sh
Shares Diluted Q1 2025 · Mar 31, 2024 182.35M sh
Capex Q1 2025 · Mar 31, 2025 $31.17M
Capex Q1 2025 · Mar 31, 2024 $37.65M
Operating Cash Flow Q1 2025 · Mar 31, 2025 $30.81M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$82.31M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $347.13M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $600.89M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $347.49M
Stockholders Equity Q1 2025 · Mar 31, 2025 $2.4B
Stockholders Equity Q1 2025 · Dec 31, 2024 $2.4B
Stockholders Equity Q1 2025 · Mar 31, 2024 $3.13B
Stockholders Equity Q1 2025 · Dec 31, 2023 $3.15B
Current Liabilities Q1 2025 · Mar 31, 2025 $502.47M
Current Liabilities Q1 2025 · Dec 31, 2024 $732.19M
Total Liabilities Q1 2025 · Mar 31, 2025 $3.31B
Total Liabilities Q1 2025 · Dec 31, 2024 $3.53B
Current Assets Q1 2025 · Mar 31, 2025 $1.37B
Current Assets Q1 2025 · Dec 31, 2024 $1.57B
Total Assets Q1 2025 · Mar 31, 2025 $5.71B
Total Assets Q1 2025 · Dec 31, 2024 $5.93B
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.54
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.60
Eps Basic Q1 2025 · Mar 31, 2025 −$0.54
Eps Basic Q1 2025 · Mar 31, 2024 −$0.60
Sga Expense Q1 2025 · Mar 31, 2025 $220.69M
Sga Expense restated Q1 2025 · Mar 31, 2024 $219.65M
Rd Expense Q1 2025 · Mar 31, 2025 $105.31M
Rd Expense restated Q1 2025 · Mar 31, 2024 $110.87M
Net Income Q1 2025 · Mar 31, 2025 −$101.22M
Net Income Q1 2025 · Mar 31, 2024 −$110.23M
Operating Income Q1 2025 · Mar 31, 2025 −$96.01M
Operating Income Q1 2025 · Mar 31, 2024 −$106.69M
Gross Profit Q1 2025 · Mar 31, 2025 $500.55M
Gross Profit Q1 2025 · Mar 31, 2024 $446.32M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $206.24M
Cost Of Revenue restated Q1 2025 · Mar 31, 2024 $191.2M
Revenue Q1 2025 · Mar 31, 2025 $706.79M
Revenue Q1 2025 · Mar 31, 2024 $637.52M